-
Mashup Score: 1
Purpose:Efficacy and safety of vibegron, a β3-adrenergic receptor agonist, was assessed among men with symptoms of overactive bladder (OAB) receiving pharmacologic treatment for benign prostatic hyperplasia (BPH) in a phase 3 randomized controlled trial….
Source: www.auajournals.orgCategories: General Medicine News, UrologyTweet
-
Mashup Score: 2Telemedicine Utilization in the COVID-19 Era: Patterns of Care in Community Urology Practice | Urology Practice - 3 day(s) ago
Introduction:The acute phase of the COVID-19 pandemic disrupted ambulatory care in the US, and in response telemedicine was adopted rapidly but unevenly across specialties and time. This study examines the utilization of telemedicine in the specialty of …
Source: www.auajournals.orgCategories: General Medicine News, UrologyTweet
-
Mashup Score: 30
Purpose:The summary presented herein covers recommendations on salvage therapy for recurrent prostate cancer intended to facilitate care decisions and aid clinicians in caring for patients who have experienced a recurrence following prior treatment with …
Source: www.auajournals.orgCategories: General Medicine News, UrologyTweet
-
Mashup Score: 2MP75-09 HOW NOCTURIA CAN HELP A UROLOGIST DIAGNOSE A SLEEP DISORDER | Journal of Urology - 8 day(s) ago
INTRODUCTION AND OBJECTIVE:There is a well-established association between obstructive sleep apnea (OSA) and nocturia. However, it is not common practice for nocturia patients to receive a complete workup for underlying OSA. The majority of patients who …
Source: www.auajournals.orgCategories: General Medicine News, UrologyTweet
-
Mashup Score: 15MP76-06 IMPACT OF DOBBS v. JACKSON WOMEN’s HEALTH ORGANIZATION ON INCIDENCE OF CHILDLESS AND PARTNERLESS VASECTOMY | Journal of Urology - 8 day(s) ago
INTRODUCTION AND OBJECTIVE:The Supreme Court ruling Dobbs v. Jackson Women’s Health Organization (June 2022) overturned federal protection of abortion rights, significantly impacting female and male reproductive health. We compared incidence of childless …
Source: www.auajournals.orgCategories: General Medicine News, UrologyTweet
-
Mashup Score: 3PD60-04 “LINK IN MY BIO”: COMMERCIAL BIAS IN ERECTILE DYSFUNCTION TREATMENT VIDEOS ON SOCIAL MEDIA PLATFORMS | Journal of Urology - 8 day(s) ago
INTRODUCTION AND OBJECTIVE:Patients are increasingly turning to social media platforms for health information, particularly on sensitive topics like erectile dysfunction (ED) treatment. Social media “influencers” have, in turn, commercialized their …
Source: www.auajournals.orgCategories: General Medicine News, UrologyTweet
-
Mashup Score: 8MP68-09 THE ASSOCIATION BETWEEN 5-ALPHA REDUCTASE INHIBITORS AND PROSTATE CANCER MORTALITY | Journal of Urology - 8 day(s) ago
INTRODUCTION AND OBJECTIVE:5-alpha-reductase-inhibitors (5-ARIs), finasteride and dutasteride, are approved for treating benign prostatic hyperplasia (BPH), and reduce prostate cancer risk by 25%. However, trials also showed 5-ARI use to be associated …
Source: www.auajournals.orgCategories: General Medicine News, UrologyTweet
-
Mashup Score: 11
Background:Nadofaragene firadenovec-vncg is a non-replicating adenoviral vector–based gene therapy for BCG-unresponsive carcinoma in situ (CIS) with/without HG Ta/T1). We report outcomes following 5 years of planned follow-up.Methods:This open-label phase …
Source: www.auajournals.orgCategories: General Medicine News, UrologyTweet
-
Mashup Score: 7MP68-05 EXCESS DEATH AND POTENTIAL LIFE YEARS LOST AMONG BLACK PROSTATE CANCER PATIENTS (1970-2020) | Journal of Urology - 8 day(s) ago
INTRODUCTION AND OBJECTIVE:Prostate cancer demonstrates a wide and sustained disparity in mortality among Black Americans compared with the average US population. These disparities have persisted over 50 years despite significant diagnostic and …
Source: www.auajournals.orgCategories: General Medicine News, UrologyTweet
-
Mashup Score: 6MP68-08 PHYSICIAN DENSITY AND PROSTATE CANCER MORTALITY IN THE US FROM 2011-2020 | Journal of Urology - 8 day(s) ago
INTRODUCTION AND OBJECTIVE:Prostate cancer is the second leading cause of cancer death in men in the United States, accounting for more than 34,000 deaths in 2023. Prior research suggests that prostate cancer mortality is highest in areas underserved by …
Source: www.auajournals.orgCategories: General Medicine News, UrologyTweet
PATHWAY TO PUBLICATION: Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 Randomized Controlled COURAGE Trial #AUA24 https://t.co/PKI5Uwhymt